Partnering News

12.21.2012

Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase

12.20.2012

Humedica and Pfizer Form Strategic Alliance

11.30.2012

Pfizer Completes Sale of Nutrition Business to Nestlé

11.28.2012

Pfizer Acquires NextWave Pharmaceuticals, Inc.

11.19.2012

Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer

09.12.2012

Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.

08.31.2012

VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody

08.13.2012

Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium

08.09.2012

Nodality Enters into a Multi-Year Strategic Collaboration with Pfizer in Autoimmune Disease

07.11.2012

VERASTEM ACQUIRES CLINICAL-STAGE FAK INHIBITOR FROM PFIZER

05.01.2012

Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™ (taliglucerase alfa) For The Treatment Of Gaucher Disease

04.23.2012

Quark Pharmaceuticals Announces Phase 2a Study of PF--04523655 (PF-655) in Patients with Moderate and Advanced OpenAngle Glaucoma (OAG